CYP2W1 and hepatocellular carcinoma: Clinically, CYP2W1 upregulation has been associated with tumor aggressiveness, including higher metastatic potential, advanced histological differentiation, and advanced tumor stage, making it a potential biomarker for poor prognosis in colorectal cancer and hepatocellular carcinoma [12,13,14].